Monday, 26 October 2026LatestVideosAboutContact
Latest
JWST and ALMA reveal a dusty, rapidly growing black hole in the early universeCan we really predict the future? Over one million forecasts offer clues, not certaintyHMWSSB fines Paradise Biryani Rs 20k for wasting drinking waterS&P sees 15-20% EBITDA growth for ONGC in FY27 on upstream strength, downstream recoveryAnother day, another viral dessert enters Hyderabad’s food sceneCan AI help solve the COBOL code crisis?‘Scene’: Suriya’s DSP Inbaraj asks crowds to shoot reels verticallyHyundai introduces compact SUV Bayon starting ₹10 lakhPrivate logistics players tap India Post to expand last-mile reachSC asks States, UTs to allocate funds to build bar rooms, washrooms for women advocatesFarokh Engineer calls for a stand named after James Anderson at Old TraffordUniversity of Hyderabad hosts global drug discovery programme
BusinessUpdated 1 hr ago

Mankind Pharma Q2 PAT rises 37.7% on strong domestic chronic business

Business Standard26 October 2026 at 5:40 pm IST
Image: Business Standard

The drugmaker's revenue rose 17.3 per cent to ₹4,338 crore in Q2 FY27, supported by strong demand for chronic therapies and growth in Bharat Serums and Vaccines' speciality portfolio.

Continue reading on Business Standard

Hello Headlines links you to the original publisher for the full story.

Read full story

More in Business

See all

Hyundai introduces compact SUV Bayon starting ₹10 lakh

The Hindu10 min ago

Private logistics players tap India Post to expand last-mile reach

BusinessLine11 min ago

SC asks States, UTs to allocate funds to build bar rooms, washrooms for women advocates

BusinessLine14 min ago

Indian Railways extends optional travel insurance to counter-ticket buyers, mandates digital payment

BusinessLine17 min ago